Hussman Strategic Advisors’s Harvard Bioscience HBIO Stock Holding History

Hussman Strategic Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-90,800	Closed	-$5.15M	–	199
2014 Q4	$5.15M	Sell	90,800 -2,200	-2%	-$105K	0.51%	81
2014 Q3	$3.8M	Hold	93,000	–	–	0.33%	112
2014 Q2	$4.23M	Hold	93,000	–	–	0.33%	105
2014 Q1	$4.41M	Hold	93,000	–	–	0.33%	100
2013 Q4	$4.37M	Sell	93,000 -38,900	-29%	-$1.7M	0.31%	103
2013 Q3	$5.26M	Hold	131,900	–	–	0.29%	101
2013 Q2	$4.73M	Buy	+131,900	New	+$5.05M	0.22%	122

Other funds holding HBIO

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return